• Latest Posts

Update: British Biotech Starts Phase II Trial in the Second Deadliest Cancer

In Depth 12 Jul 2017

Genomic Testing in Oncology: From Single Genes to Whole Genomes

Novartis largely dodged deaths from its CAR-T therapy, but FDA still has safety concerns

Results are in from the First Human Trial of an Universal Cancer Vaccine

Cutting Through the BS in Biopharma: How To Spot Hype

British Liquid Biopsy for Ovarian Cancer Outperforms the Gold Standard

ADVERTISEMENT

Belgian Biotech Starts Phase Ib with an off-the-shelf mRNA Therapy for Melanoma

Servier Recruits Viral Vector Expert to Step Up its CAR-T Technology

UPDATE: The First Off-the-Shelf CAR-T Cancer Therapy has Entered the Clinic

What are the Biggest Cancer Challenges? The UK Offers £20M Prizes for Solutions!

Swedish Biotech publishes Long-Term Data on a Dendritic Cell Therapy for Cancer

Interview 20 Jun 2017

“We’re at a second revolution in cancer therapy” – Experts discuss the Future of Oncology at Refresh

ADVERTISEMENT